Costunolide exhibits significant anticancer properties in different leukemia cell lines, particularly K562, HL-60, THP-1, and Molt-4, either by inducing cell cycle arrest or apoptosis, or by inhibition of NFκB activation [8,11]. This evidence concerns the gene NFKB1 and leukemia.